The synergy is mechanistic, not anecdotal
Reisman was part of a group of doctors with the Food and Drug Administration who evaluated the dipyridamole thallium testing technique before the FDA approved it
The most frequent side effect is mild to moderate nausea, particularly at the beginning of treatment or following a dose increase
In a public warning on Thursday, Lilly said its own testing has unearthed potential safety issues in personalized forms of tirzepatide, the active ingredient in Zepbound
When rapid weight loss outpaces the skin's natural remodeling process, sagging and crepiness can result
Even if the impact would be bigger than that, I think over a 10-year period, it will be manageable, and we will have adequate lead time to adjust and prepare for any changes that we see. On a more practical note, he said, Obesity rates around the world are very different, and we have one of the lowest exposures since 75% of our sales come from outside of the US and 40% of our sales are in emerging markets [where average BMIs are far lower]